AW

Alexa Willson

Chief Financial Officer

Eureka Therapeutics

Therapeutic Areas

Eureka Therapeutics Pipeline

DrugIndicationPhase
ECT204Advanced Hepatocellular Carcinoma (HCC)Phase 1/2